Inhibrx Biosciences Inc (INBX)
SG&A Expense Growth
44.66%
Quarterly · Period ending:
INBX SG&A Expense Growth
Latest reported44.66%period ending
Latest reported44.66%period ending
INBX Quarterly SG&A Growth (QoQ) (0.00% → 44.66%)
Latest values, visible window
High-resolution chart · PNG
INBX sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 44.6607% | |
| 2.3143% | |
| 5.6282% | |
| -17.8293% | |
| 6.6069% | |
| -63.8437% | |
| 113.4931% | |
| -91.6415% | |
| 845.9574% | |
| 26.766% | |
| -1.3056% | |
| 9.4175% | |
| 12.7091% | |
| 20.1766% | |
| -0.4488% | |
| -1.0181% | |
| 17.18% | |
| 56.1124% | |
| 3.6868% | |
| -0.1753% | |
| -5.1844% | |
| 35.8465% | |
| 36.5598% | |
| 5.8747% | |
| 4.4308% | |
| -66.9147% | |
| 199.3923% | |
| -9.4743% | |
| 11.5201% | |
| -12.2083% | |
| 0% | |
| 8.562% | |
| 3.5227% | |
| 0% |